We are live on ! Find out more
VGNT icon

Versigent

445 hedge funds and large institutions have $3.03B invested in Versigent in 2026 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 129 increasing their positions, 146 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

279% more call options, than puts

Call options by funds: $21.1M | Put options by funds: $5.57M

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

22% more first-time investments, than exits

New positions opened: 72 | Existing positions closed: 59

0% more funds holding

Funds holding: 443 → 445 (+2)

3.7% less ownership

Funds ownership: 98.69% → 94.98% (-3.7%)

12% less repeat investments, than reductions

Existing positions increased: 129 | Existing positions reduced: 146

18% less capital inflows, than outflows

Capital inflows: $409M | Capital outflows: $499M

Holders
445
Holders Change
+2
Holders Change %
+0.45%
% of All Funds
5.41%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
72
Increased
129
Reduced
146
Closed
59
Calls
$21.1​M
Puts
$5.57​M
Net Calls
+$15.5​M
Net Calls Change
-⁠$3.47​M

VGNT Hedge Fund Activity: Q3 2026 in Review

445 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Versigent (VGNT) for Q3 2026, worth a combined $3.03B — up 3.9% from $2.91B a quarter earlier.

Buyers outnumbered sellers: 72 funds opened new VGNT positions and 59 closed out — a net gain of 13 holders — while 129 added to existing stakes and 146 trimmed.

The largest buyer was DME Capital Management, adding an estimated $42M. The largest seller was Amundi, cutting an estimated $25.9M.

  • 445 institutional investors held Versigent (VGNT) as of Q3 2026, up from 443 in Q2 2026.
  • Funds reported $3.03B of Versigent stock for Q3 2026, up 3.9% quarter-over-quarter.
  • 72 funds opened new Versigent positions in Q3 2026 and 59 closed out, a net change of +13 holders.
  • The largest Versigent buyer in Q3 2026 was DME Capital Management, an estimated $42M added.
  • The largest Versigent seller in Q3 2026 was Amundi, an estimated $25.9M sold.

Based on aggregated 13F filings for Q3 2026.